Haleos Labs Ltd

Fri 18/09/2026,15:50:4 | NSE : HALEOSLABS

₹1497.604.60 (0.31%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1493.50

Previous Close

₹ 1493.00

Volume

777

Mkt Cap ( ₹ Cr)

₹ 452.77

High

₹ 1524.90

Low

₹ 1470.00

52 Week High

₹ 1774.00

52 Week Low

₹ 1091.10

Book Value Per Share

₹ 712.43

Dividend Yield

0.10

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Haleos Labs Ltd

Your Vote -

Buy

38.64%

Hold

11.36%

Sell

50.00%

38.64%

44 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1497.60

47

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

47

Option Chain

Analyzes market sentiment, predicts Haleos Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Haleos Labs - USFDA Update (Material Subsidiary)

    18 Sep 2026, 11:53AM Update on the material subsidiary of the Company.

  • Haleos Labs has declared 15% Final dividend for the financial year March 2026

    13 Sep 2026, 6:20PM Haleos Labs Ltd. on Friday, 29 May 2026, has announced Final dividend of 15 percent on Equity Share, to its shareholders holding shares on the registe

  • Haleos Labs - Updates

    9 Sep 2026, 7:02PM HALEOS LABS LIMITED has informed the Exchange regarding 'Annual Report (Weblink)'.

  • Haleos Labs - Annual Report (Weblink)

    9 Sep 2026, 6:58PM Communication to physical shareholders providing them with the link to the Annual Report and AGM Notice.

  • Haleos Labs - Copy of Newspaper Publication

    8 Sep 2026, 5:29PM HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication for AGM notice

  • Haleos Labs - Shareholders meeting

    8 Sep 2026, 5:13PM HALEOS LABS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

  • Haleos Labs - Newspaper Advertisement (AGM Notice)

    8 Sep 2026, 5:26PM Enclosed newspaper advertisement for the AGM Notice.

  • Haleos Labs - AGM Notice (Sept 30, 2026)

    8 Sep 2026, 5:08PM Enclosed - 20th AGM Notice.

  • Haleos Labs - Reg. 34 (1) Annual Report.

    8 Sep 2026, 4:34PM Enclosed Annual Report for the year ended 31st March, 2026.

  • Haleos Labs - General Updates

    5 Sep 2026, 7:12PM HALEOS LABS LIMITED has informed the Exchange about Events Calendar (AGM)

  • Haleos Labs - Record Date

    5 Sep 2026, 7:09PM HALEOS LABS LIMITED has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.

  • Haleos Labs - Record Date (Dividend)

    5 Sep 2026, 7:00PM The record date for the dividend (F26) and the 20th AGM will be Wednesday, September 23, 2026.

  • Haleos Labs - Events Calendar (AGM)

    5 Sep 2026, 6:53PM Events calendar for the 20th Annual General Meeting.

  • Haleos Labs - Shareholders meeting

    1 Sep 2026, 11:37AM HALEOS LABS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding v

  • Haleos Labs - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    1 Sep 2026, 11:18AM Outcome of Postal Ballot.

  • Haleos Labs - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    1 Sep 2026, 11:15AM Outcome of Board meeting.

  • Haleos Labs - Updates

    24 Aug 2026, 3:11PM HALEOS LABS LIMITED has informed the Exchange regarding 'Communication To Shareholders (TDS Related)'.

  • Haleos Labs - Communication To Shareholders (TDS Related)

    24 Aug 2026, 3:04PM Enclosed email communication sent to Shareholders.

  • Haleos Labs Q1 net profit down 37.21% at Rs 3.24 cr

    19 Aug 2026, 8:20PM The company reported standalone net profit of Rs 3.24 crore for the quarter ended June 30, 2026 as compared to Rs 5.16 crore in the same period last y

  • Haleos Labs - Copy of Newspaper Publication

    7 Aug 2026, 1:12PM HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

  • Haleos Labs - Newspaper Publication (Financial Results)

    7 Aug 2026, 1:08PM Enclosed -- newspaper advertisement for Q1F27 results.

  • Haleos Labs - Updates

    5 Aug 2026, 3:19PM HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.

  • Haleos Labs - Change in Director(s)

    5 Aug 2026, 2:38PM HALEOS LABS LIMITED has informed the Exchange regarding Change in Director(s) of the company.

  • Haleos Labs - Outcome of Board Meeting

    5 Aug 2026, 1:48PM HALEOS LABS LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Haleos Labs - Update (Material Subsidiary)

    5 Aug 2026, 3:16PM Mahi Drugs Private Limited appointed Cost Auditors for the year 2026-27 and Mr. Vincent P Asrao as Nominee Director.

  • Haleos Labs - Independent Directors (Reappointed)

    5 Aug 2026, 2:33PM Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam were reappointed for a second term of 5 years w.e.f. November 13, 2026, subject to approval of shar

  • Haleos Labs - Board Meeting Outcome for Meeting Held On Aug 5, 2026

    5 Aug 2026, 1:49PM Enclosed - Outcome of 98th Board meeting.

  • Haleos Labs - Board Meeting Intimation for 98Th Board Meeting (05.08.2026)

    1 Aug 2026, 6:50PM Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and appr

  • Haleos Labs - Copy of Newspaper Publication

    30 Jul 2026, 12:47PM HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication (Postal Ballot)

  • Haleos Labs - Newspaper Publication (Postal Ballot)

    30 Jul 2026, 12:44PM Enclosed - Newspaper advertisement.

  • Haleos Labs - Shareholders meeting

    29 Jul 2026, 7:09PM HALEOS LABS LIMITED has informed the Exchange regarding Notice of Postal Ballot

  • Haleos Labs - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    29 Jul 2026, 7:04PM Postal Ballot Notice (30.07.2026 to 28.08.2026)

  • Haleos Labs - Updates

    29 Jul 2026, 3:57PM HALEOS LABS LIMITED has informed the Exchange regarding 'Events Calendar (Postal Ballot)'.

  • Haleos Labs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    7 Jul 2026, 8:10PM As of June 2026, 72.10% is owned by Indian Promoters and 27.89% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ha

  • Haleos Labs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jul 2026, 10:53AM HALEOS LABS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Haleos Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 10:42AM Enclosed -- RTA certificate.

  • SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir

    20 Jan 2022 , 3:43PM Molnupiravir is the first oral, direct-acting antivral shown to be highly effective at reducing infectious virus
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Haleos Labs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 307.6849 276.348 264.957 249.1726 210.9553
Liabilities 307.6849 276.348 264.957 249.1726 210.9553
Equity 3.0233 3.0233 3.0233 3.0233 3.0233
Gross Profit 40.4682 44.2317 34.4313 26.4065 31.3647
Net Profit 17.7768 21.3708 13.0654 13.2176 25.3813
Cash From Operating Activities 38.4304 28.0325 14.7514 4.5753 -14.6554
NPM(%) 5.9 6.41 4.35 4.19 7.34
Revenue 300.9896 333.371 300.0016 315.2418 345.6281
Expenses 260.5214 289.1393 265.5703 288.8353 314.2634
ROE(%) 8.25 9.92 6.06 6.13 11.78

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
23 Sep 2026 1.5 15 0.1 1581.3
1.5 15 0.1 1373.4
23 Sep 2024 1.5 15 0.1 696.3
22 Sep 2022 1.5 15 0.1 637.6
20 Sep 2021 1.5 15 0.1 659.8
19 Sep 2019 1.5 15 0.1 483.4

Peers

Other companies within the same industry or sector that are comparable to Haleos Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 833.60 -0.58 21.08 840.84 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 115.10 1.75 1644.29 3063.92 0.39 0.00
Vaishali Pharma Ltd 8.79 0.11 27.47 19220.98 15.42 0.00
Astec Lifesciences Ltd 726.70 -3.77 0.00 3282.82 -363.14 0.00

Company Info

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

Parent Organisation

Haleos Labs Ltd.

Founded

31/05/2006

Managing Director

Mr.TVVSN Murthy

NSE Symbol

HALEOSLABSEQ

FAQ